Innoviva (INVA) Other Accumulated Expenses (2010 - 2026)

Innoviva (INVA) has 17 years of Other Accumulated Expenses data on file, last reported at $3.9 million in Q1 2026.

• Quarterly Other Accumulated Expenses rose 17.57% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 17.57% YoY) and the FY2025 annual result came in at $3.7 million, up 25.04% from the prior year.
• Other Accumulated Expenses rose to $3.9 million in Q1 2026, from $3.7 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $24.9 million in Q1 2023 to a low of $1.9 million in Q4 2023.
• A 5-year average of $11.7 million and a median of $8.1 million in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses jumped 2043.0% — and 2023, when it tumbled 90.91%.
• Tracing INVA's Other Accumulated Expenses over 5 years: stood at $21.2 million in 2022, then plunged by 90.91% to $1.9 million in 2023, then soared by 53.06% to $3.0 million in 2024, then grew by 25.04% to $3.7 million in 2025, then gained by 6.29% to $3.9 million in 2026.
• The last three Other Accumulated Expenses figures came in at $3.9 million (Q1 2026), $3.7 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.